Keywords: imclone, completes, enrollment, cancer, vaccine, trial, systems

ImClone completes enrollment in cancer vaccine trial

Article | 25 April 2001

Print This

ImClone Systems and Merck KGaA have achieved a patient enrollmentmilestone in a Phase III clinical trial for the former company's ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in